Transcriptomics aids differentiation of IL-23 overactivity in a patient with atypical skin and joint disease. Hakimi M, North JP, Taylor MA, Hailer A, et al. Lancet 2023;401:1381.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hakimi M, North JP, Taylor MA, Hailer A, et al. Transcriptomics aids differentiation of IL-23 overactivity in a patient with atypical skin and joint disease. Lancet 2023;401:1381.
PMID: 37087172